Patent Assignment
Reel/Frame 045019/0552
Security Interest
Recorded: 2018-01-08
Pages: 59
Assignors
MELINTA THERAPEUTICS, INC.
Executed: 2018-01-05
REMPEX PHARMACEUTICALS, INC.
Executed: 2018-01-05
CEMPRA PHARMACEUTICALS, INC.
Executed: 2018-01-05
CEM-102 PHARMACEUTICALS, INC.
Executed: 2018-01-05
Assignee
CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
225 W WASHINGTON ST., 9TH FLOOR, CHICAGO, ILLINOIS, 60606
Covered Properties
(113)
Process for the Synthesis of Biaryl Oxazolidinones
Macrocyclic Compounds and Methods of Making and Using the Same
Bifunctional Heterocyclic Compounds and Methods of Making and Using Same
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Halogenated Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Bifunctional Heterocyclic Compounds and Methods of Making and Using Same
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Process for the Synthesis of Triazoles
Triazole compounds and methods of making and using the same
Triazole Compounds and Methods of Making and Using the Same
Protein Synthesis Modulators
Patent:
8,374,794 →
Application:
12/072,980 →
Protein Synthesis Modulators
Patent:
8,428,884 →
Application:
12/074,200 →
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Use of Oritavancin for Prevention and Treatment of Anthrax
Fusidic Acid Dosing Regimens for Treatment of Bacterial Infections
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Process for the Preparation of Macrolide Antibacterial Agents
Methods of Treating Bacterial Infections Using Oritavancin
Methods of Treating Urethritis and Related Infections Using Fusidic Acid
Methods of Inhibiting and Treating Biofilms Using Glycopeptide Antibiotics
Methods of Treatment Using Single Doses of Oritavancin
Process for Making Quinolone Compounds
Biodefenses Using Triazole-Containing Macrolides
Methods for Treating Gastrointestinal Diseases
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof
Glycopeptide and Lipoglycopeptide Antibiotics with Improved Solubility
Methods for Treating Malaria, Tuberculosis and Mac Diseases
Antimicrobial Compounds and Methods of Making and Using the Same
Antimicrobial Compounds and Methods of Making and Using the Same
Antimicrobial Compounds and Methods of Making and Using the Same
Macrocyclic Compounds and Methods of Making and Using the Same
Disk Diffusion Assay for Oritavancin
Parenteral Formulations of Macrolide Antibiotics
Application:
13/583,556 →
Publication:
US 2013/0045937
Process for the Synthesis of Biaryl Oxazolidinones
Crystalline Forms of a Macrolide, and Uses Therefor
Tetracycline Compositions
Process for Preparing Triazole-Containing Ketolide Antibiotics
Methods of Treatment Using Single Doses of Oritavancin
Hydrogen Bond Forming Fluoro Ketolides for Treating Diseases
Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof
Process for the Syntheses of Triazoles
Sustained Release Pharmaceutical Compositions Comprising an Antibacterial Agent
Crystalline Forms of a Macrolide, and Uses Therefor
Triazole Compounds and Methods of Making and Using the Same
Process for Making Quinolone Compounds
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof
Triazole Compounds and Methods of Making and Using the Same
Method of Inhibiting Clostridium Difficile by Administration of Oritavancin
Antimicrobial Compounds and Methods of Making and Using the Same
Compositions Comprising Fusidic Acid and Packages Therefor
Application:
14/119,542 →
Publication:
US 2014/0088062
Tetracycline Compositions
Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
Methods for Treating Gastrointestinal Diseases
Methods for Treating Resistant Diseases Using Triazole Containing Macrolides
Process for the Synthesis of Triazoles
Parenteral Formulations for Administering Macrolide Antibiotics
Pharmaceutical Compositions of Oxazolidinone Antimicrobial Agents
Application:
14/630,584 →
Publication:
US 2015/0165040
Antimicrobial Compounds and Methods of Making and Using the Same
Processes for Preparing Macrolides and Ketolides and Intermediates Therefor
Application:
14/702,004 →
Publication:
US 2015/0232500
Biodefenses Using Triazole-Containing Macrolides
Process for Making Quinolone Compounds
Patent:
46,617 →
Application:
14/743,365 →
Antimicrobial Compositions with Effervescent Agents
Application:
14/744,432 →
Publication:
US 2015/0366857
Methods for Treating Respiratory Diseases and Formulations Therefor
Convergent Processes for Preparing Macrolide Antibacterial Agents
Methods of Treating Infections in Overweight and Obese Patients Using Antibiotics
Treatment and Prevention of Bacterial Skin Infections Using Oritavancin
Application:
14/786,106 →
Publication:
US 2016/0101148
High Purity Oritavancin and Method of Producing Same
Crystalline Forms of a Macrolide, and Uses Therefor
Application:
14/859,736 →
Publication:
US 2016/0244472
Antimicrobial Compounds and Methods of Making and Using the Same
Application:
14/880,503 →
Publication:
US 2016/0031893
Antimicrobial Compounds and Methods of Making and Using the Same
Methods for Treating Bacterial Infections Using Oritavancin and Polymyxins
Methods for Treating Bacteremia and Osteomyelitis Using Oritavancin
Application:
14/914,792 →
Publication:
US 2016/0206688
Antimicrobial Compounds and Methods of Making and Using the Same
Antimicrobial Compounds and Methods of Making and Using the Same
Antimicrobial Compounds and Methods of Making and Using the Same
Application:
14/932,508 →
Publication:
US 2019/0322668
Method for Treating, Preventing, or Reducing the Risk of Skin Infection
Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof
Antimicrobial Compositions
Application:
15/042,886 →
Publication:
US 2016/0235736
Compositions and Methods for Treating Diabetes and Liver Diseases
Application:
15/118,124 →
Publication:
US 2017/0165286
Methods of Treating Bacterial Infections
Application:
15/134,198 →
Publication:
US 2016/0339045
Pharmaceutical Compositions
Process for the Preparation of Macrolide Antibacterial Agents
Synthesis of Boronate Salts and Uses Thereof
Salts and Polymorphs of Cyclic Boronic Acid Ester Derivatives and Therapeutic Uses Thereof
Compositions and Methods for Treating Bone and Joint Infections
Application:
15/317,578 →
Publication:
US 2017/0119793
Antimicrobial Compounds And Methods Of Making And Using The Same
Triazole Compounds and Methods of Making and Using the Same
Application:
15/404,757 →
Publication:
US 2017/0349621
Oritavancin Formulations
Application:
15/436,391 →
Publication:
US 2017/0239323
High Purity Oritavancin and Method of Producing Same
Macrocyclic Compounds And Methods Of Making And Using The Same
Application:
15/493,344 →
Publication:
US 2018/0066007
Powder Oral Suspension Formulations of Antibacterial Agents
Application:
15/501,516 →
Publication:
US 2017/0224664
Apparatus and Continuous Flow Process for Production of Boronic Acid Derivatives
Antimicrobial Compounds And Methods Of Making And Using The Same
Topical Formulations of Biaryl Heterocyclic Compounds and Methods of Use Thereof
Application:
15/593,608 →
Publication:
US 2017/0333400
Triazole Compounds And Methods Of Making And Using The Same
Application:
15/597,701 →
Publication:
US 2018/0094016
Cyclic Boronic Acid Ester Derivatives and Methods of Making the Same
Tetracycline Compositions
Application:
15/660,698 →
Publication:
US 2018/0078570
Methods for Treating Infections
Application:
15/696,603 →
Publication:
US 2017/0368055
Processes for Preparing Fluoroketolides
Application:
62/382,887 →
Methods of Treating Bacterial Infections
Application:
62/444,238 →
Apparatus and Continuous Flow Process for Production of Boronic Acid Derivative
Application:
62/453,408 →
Triazole-Containing Macrolides and Ophthalmic Uses Therefor
Application:
62/460,143 →
Triazole-Containing Macrolides and Ophthalmic Uses Therefor
Application:
62/467,973 →
Triazole Compounds and Methods of Making and Using the Same
Application:
62/485,909 →
Methods of Treating Bacterial Infections
Application:
62/513,936 →
Antimicrobials and Methods of Making and Using Same
Application:
62/521,835 →
Antimicrobials and Methods of Making and Using Same
Application:
62/522,574 →
Method of Treating Bacterial Infections
Application:
62/567,702 →
Synthesis of Boronate Ester Derivatives and Uses Thereof
Application:
62/580,343 →
Antimicrobials and Methods of Making and Using Same
Application:
62/593,445 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 12, 2012
From: WIMBERLY, BRIAN
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 029453/0626 →
Change of Name
Oct 17, 2013
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031432/0123 →
Assignment of Assignor's Interest
Oct 17, 2013
From: TARGANTA THERAPEUTICS CORP.
To: THE MEDICINES COMPANY
Reel/Frame 031428/0744 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0718 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0731 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0650 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0654 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0664 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0691 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMCEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0710 →
Change of Name
Jan 13, 2014
From: RIB-X PHARMCEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 031997/0714 →
Assignment of Assignor's Interest
Sep 24, 2014
From: ZHOU, JIACHENG; BHATTACHARJEE, ASHOKE; CHEN, SHILI; CHEN, YI
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 033811/0114 →
Change of Name
Sep 24, 2014
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 033813/0633 →
Assignment of Assignor's Interest
Sep 24, 2014
From: SPRINGER, DANE M.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 033811/0144 →
Assignment of Assignor's Interest
Sep 24, 2014
From: WANG, DEPING; SUTCLIFFE, JOYCE A.; OYELERE, ADEGBOYEGA K.; MCCONNELL, TIMOTHY S.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 033811/0093 →
Security Interest
Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
Release of Security Interest
Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
Merger and Change of Name
Aug 30, 2018
From: MELINTA THERAPEUTICS, INC.; MELINTA SUBSIDIARY CORP.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 046752/0975 →
Release of Security Interest
Jan 10, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
To: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
Reel/Frame 047949/0754 →
Assignment of Assignor's Interest
Jan 12, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: ARREVUS, INC.
Reel/Frame 047978/0933 →
Assignment of Assignor's Interest
Jan 16, 2019
From: MELINTA THERAPEUTICS, INC.
To: MELINTA SUBSIDIARY CORP.
Reel/Frame 048030/0489 →
Assignment of Assignor's Interest
Feb 21, 2019
From: THE MEDICINES COMPANY
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048407/0911 →
Release of Security Interest
Apr 11, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048875/0750 →
Release of Security Interest
Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →
Assignment of Assignor's Interest
Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →